OpGen Inc released its earnings results on Aug 08, 2024. The company reported -$1.176 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.176.

Q: Is OpGen Inc overvalued?

According to Wall Street analysts OpGen Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does OpGen Inc pay dividends?

OpGen Inc does not currently pay dividends.

Q: What is OpGen Inc’s EPS estimate?

OpGen Inc’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does OpGen Inc have?

OpGen Inc has 10,071,293 shares outstanding.

Q: What happened to OpGen Inc’s price movement after its last earnings report?

OpGen Inc reported an EPS of -$1.176 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.5%.

Q: Which hedge fund is a major shareholder of OpGen Inc?

Currently, no hedge funds are holding shares in OPGN

Compare

595 Followers

OPGN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$0.04 - $5.25

Previous CloseN/A

Volume983.00

Average Volume (3M)1.29K

Market Cap

$1.01K

Enterprise Value$13.75M

Total Cash (Recent Filing)$1.31M

Total Debt (Recent Filing)$2.11M

Price to Earnings (P/E)<0.1

Beta11.50

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-12.96

Shares Outstanding10,071,293

10 Day Avg. Volume0

30 Day Avg. Volume1,287

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap13.65K

Enterprise Value/Revenue2.65

Enterprise Value/Gross Profit2.69

Enterprise Value/Ebitda1.33

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

OpGen News

OpGen Delays Filing of Quarterly Report

OpGen ( ($OPGN) ) has released a notification of late filing. OpGen, Inc. has announced a delay in...

1M ago

OPGN

OpGen Director Resigns, Joins CapForce Leadership

The latest announcement is out from OpGen ( ($OPGN) ). OpGen, Inc. announced on July 17, 2025, that...

2M ago

OPGN

OpGen Forms Joint Venture with European Bank

OpGen ( ($OPGN) ) has shared an announcement. OpGen, Inc., through its subsidiary CapForce International Holdings Ltd., is...

4M ago

OPGN

OpGen Delays 10-Q Filing Amid Operational Challenges

OpGen ( ($OPGN) ) has released a notification of late filing. OpGen, Inc. has announced a delay in...

4M ago

OPGN

OpGen Delays Yearly Report Amid Operational Challenges

OpGen ( ($OPGN) ) has released a notification of late filing. OpGen, Inc. has announced a delay in...

6M ago

OPGN

OpGen Appoints New COO and Company Secretary

OpGen ( ($OPGN) ) has provided an announcement. OpGen, Inc. appoints Mohd Azham Azudin as COO and Gillian...

9M ago

OPGN

OpGen’s Strategic Moves Amid Nasdaq Delisting and New Financing

OpGen (OPGN) just unveiled an announcement. OpGen, Inc. has entered into a financing agreement with AEI Capital Ltd.,...

1y ago

OPGN

OpGen Bolsters Board with Five New Industry Experts

OpGen (OPGN) has issued an announcement. OpGen, Inc. has recently expanded its Board of Directors, bringing on five...

1y ago

OPGN

OpGen Leadership Changes: CEO Resigns, New Chairman Appointed

The latest update is out from OpGen (OPGN). David Lazar, CEO and Chairman of OpGen Inc., has sold...

1y ago

OPGN

OpGen trading halted, news pending

19:50 EDT OpGen trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving...

1y ago

OPGN

OpGen announces 1-for-10 reverse stock split

OpGen announced that the Company’s board of directors has approved a 1-for-10 reverse stock split of its shares...

1y ago

OPGN

OpGen receives noncompliance notice from Nasdaq

OpGen announced that it received a notice from Nasdaq indicating that the company was not in compliance with...

1y ago

OPGN

OpGen Inc Announces David Lazar as New CEO

The latest update is out from OpGen Inc (OPGN). OpGen, Inc. has appointed David Lazar as its new...

1y ago

OPGN

OpGen CEO Oliver Schacht resigns, David Lazar to succeed following investment

OpGen announced that the company entered into a securities purchase agreement with David Lazar, a private investor, pursuant...

1y ago

OPGN

OPGN FAQ

What was OpGen Inc’s price range in the past 12 months?

OpGen Inc lowest stock price was $0.04 and its highest was $5.25 in the past 12 months.

What is OpGen Inc’s market cap?

OpGen Inc’s market cap is $1.01K.

When is OpGen Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were OpGen Inc’s earnings last quarter?

OpGen Inc released its earnings results on Aug 08, 2024. The company reported -$1.176 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.176.

Is OpGen Inc overvalued?

According to Wall Street analysts OpGen Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does OpGen Inc pay dividends?

OpGen Inc does not currently pay dividends.

What is OpGen Inc’s EPS estimate?

OpGen Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does OpGen Inc have?

OpGen Inc has 10,071,293 shares outstanding.

What happened to OpGen Inc’s price movement after its last earnings report?

OpGen Inc reported an EPS of -$1.176 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.5%.

Which hedge fund is a major shareholder of OpGen Inc?

Currently, no hedge funds are holding shares in OPGN

OpGen Stock Smart Score

Neutral

Fundamentals

Return on Equity

-331.94%

Trailing 12-Months

Asset Growth

-69.84%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

OpGen Inc

OpGen, Inc. is a precision medicine company focused on combating infectious diseases through its innovative molecular diagnostics and informatics technology. The company operates in the biotechnology and healthcare sectors, providing advanced solutions for the detection and treatment of multi-drug resistant pathogens. OpGen's core products include the Acuitas AMR Gene Panel, which identifies bacterial pathogens and resistance genes, and the Unyvero platform, a rapid diagnostic system for severe infections.